Author | Barri Blauvelt

Barri Blauvelt is CEO of Innovara, a global pharmaceutical business and management development firm. She can be reached at


Diagnostic Challenges in the Era of Genetically Targeting Master Brands

May 31, 2017


Companies developing potential master brands need to begin work much earlier in the clinical development program to ensure reliable diagnostics will be available to all potential patients, writes Barri Blauvelt.

Benchmarks for Blockbuster Launches

February 01, 2003

Pharmaceutical Executive


A decade ago, pharma companies typically launched new products, observed how well they sold, and, if necessary, modified their marketing strategy and launched again. In today's competitive marketplace, there is only one rule: Get it right the first time.